Obesity, insulin resistance and comorbidities ? Mechanisms of association
Arquivos Brasileiros de Endocrinologia & Metabologia · 2014-08 · 58 (6) · 600-609
DOI: 10.1590/0004-2730000003223 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Arquivos Brasileiros de Endocrinologia & Metabologia, 2014-08. Verfasst von Ana Valeria B Castro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Divisão de Endocrinologia e Metabolismo, Departamento de Clínica Médica, FMRP-USP, Ribeirão Preto, SP, Brazil. Hauptthemen laut MEDLINE: Insulin Resistance. Die Arbeit wurde bisher 197-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Overall excess of fat, usually defined by the body mass index, is associated with metabolic (e.g. glucose intolerance, type 2 diabetes mellitus (T2DM), dyslipidemia) and non-metabolic disorders (e.g. neoplasias, polycystic ovary syndrome, non-alcoholic fat liver disease, glomerulopathy, bone fragility etc.). However, more than its total amount, the distribution of adipose tissue throughout the body is a better predictor of the risk to the development of those disorders. Fat accumulation in the abdominal area and in non-adipose tissue (ectopic fat), for example, is associated with increased risk to develop metabolic and non-metabolic derangements. On the other hand, observations suggest that individuals who present peripheral adiposity, characterized by large hip and thigh circumferences, have better glucose tolerance, reduced incidence of T2DM and of metabolic syndrome. Insulin resistance (IR) is one of the main culprits in the association between obesity, particularly visceral, and metabolic as well as non-metabolic diseases. In this review we will highlight the current pathophysiological and molecular mechanisms possibly involved in the link between increased VAT, ectopic fat, IR and comorbidities. We will also provide some insights in the identification of these abnormalities. Arq Bras Endocrinol Metab. 2014;58(6):600-9
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Divisão de Endocrinologia e Metabolismo, Departamento de Clínica Médica, FMRP-USP, Ribeirão Preto, SP, Brazil.
- Diabetes and Obesity Research Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Castro, A. V., Kolka, C. M., Kim, S. P., & Bergman, R. N. (2014). Obesity, insulin resistance and comorbidities ? Mechanisms of association. Arquivos Brasileiros de Endocrinologia & Metabologia, 58(6), 600-609. https://doi.org/10.1590/0004-2730000003223
Vancouver
Castro AV, Kolka CM, Kim SP, Bergman RN. Obesity, insulin resistance and comorbidities ? Mechanisms of association. Arquivos Brasileiros de Endocrinologia & Metabologia. 2014;58(6):600-609. doi:10.1590/0004-2730000003223
BibTeX
@article{Castro2014,
author = {Castro, Ana Valeria B and Kolka, Cathryn M and Kim, Stella P and Bergman, Richard N},
title = {Obesity, insulin resistance and comorbidities ? Mechanisms of association},
journal = {Arquivos Brasileiros de Endocrinologia & Metabologia},
year = {2014},
volume = {58},
number = {6},
pages = {600--609},
doi = {10.1590/0004-2730000003223}
}
EUVIMED